1. HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate. (1st September 2018) Authors: Andreatta, Kristen; Chang, Silvia; Martin, Ross; Acosta, Rima; Daeumer, Martin; Thielen, Alexander; Miller, Michael D.; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 79:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Issue 8 (16th May 2019) Authors: Dvory‐Sobol, Hadas; Han, Bin; Lu, Julia; Yu, Mei; Beran, Rudolf K.; Cheng, Guofeng; Martin, Ross; Svarovskaia, Evguenia; Mo, Hongmei Journal: Journal of viral hepatitis Issue: Volume 26:Issue 8(2019) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals. (1st February 2022) Authors: Moldt, Brian; Günthard, Huldrych F.; Workowski, Kimberly A.; Little, Susan J.; Eron, Joseph J.; Overton, Edgar T.; Lehmann, Clara; Rokx, Casper; Kozal, Michael J.; Gandhi, Rajesh T.; Braun, Dominique L.; Parvangada, Aiyappa; Li, Jiani; Martin, Ross; Selzer, Lisa; Cox, Stephanie; Margot, Nicolas; ... Journal: AIDS Issue: Volume 36:Number 2(2022) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 73. Interim Resistance Analysis of Long-Acting Lenacapavir in Treatment-Naïve People with HIV at 28 Weeks. (4th December 2021) Authors: VanderVeen, Laurie; Margot, Nicolas; Naik, Vidula; Chang, Silvia; Martin, Ross; Dvory-Sobol, Hadas; Rhee, Martin; Callebaut, Christian Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Suboptimal Adherence. (4th December 2021) Authors: Andreatta, Kristen; D'Antoni, Michelle L; Chang, Silvia; Parvangada, Aiyappa; Martin, Ross; Blair, Christiana; Collins, Sean E; White, Kirsten L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study. (13th January 2022) Authors: Margot, Nicolas; Vanderveen, Laurie; Naik, Vidula; Ram, Renee; Parvangada, PC; Martin, Ross; Rhee, Martin; Callebaut, Christian Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 4(2022) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance. (1st November 2020) Authors: Acosta, Rima K.; Willkom, Madeleine; Andreatta, Kristen; Liu, Hui; Martin, Ross; Parvangada, Aiyappa; Martin, Hal; Collins, Sean; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Brief Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials. (1st April 2022) Authors: D'Antoni, Michelle L.; Andreatta, Kristen; Acosta, Rima; Martin, Hal; Chang, Silvia; Martin, Ross; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 89:Number 4(2022) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance. Issue 1 (24th September 2020) Authors: Liu, Yang; Chang, Silvia; Martin, Ross; Flaherty, John; Mo, Hongmei; Feierbach, Becket Journal: Journal of viral hepatitis Issue: Volume 28:Issue 1(2021) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing. Issue 12 (11th July 2020) Authors: Liu, Yang; May, Lindsey; Liu, Xinan; Martin, Ross; Svarovskaia, Evguenia; Gaggar, Anuj; Mo, Hongmei; Feierbach, Becket Journal: Journal of medical virology Issue: Volume 92:Issue 12(2020) Page Start: 3420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗